AI Terminal
Marinomed Biotech AG
Major Shareholding Notification • Jan 26, 2021
749_mrq_2021-01-26_f58982cf-18f5-40b2-8e76-f315f05bd2a0.pdf
Major Shareholding Notification
Open in ViewerOpens in native device viewer
publication: 26.01.2021 12:19 source: http://adhoc.pressetext.com/news/1611659940461 keywords: Company / Voting rights / Marinomed Biotech AG
Holding announcement according to article 135 section 2 BörseG (ESMA 2015/1597)
Marinomed Biotech AG: Correction of a Release according to art. 135 section 2 BörseG from 25.01.2021
Korneuburg (pta023/26.01.2021/12:19) - Release of Announcement according to art. 135 section 2 BörseG
Notification of Major Holdings
1. Issuer:
Marinomed Biotech AG, Hovengasse 25, 2100 Korneuburg, Austria
2. Reason for notification:
Acquisition / disposal of shares with voting rights
3. Details of person subject to the notification obligation
Name: Acropora Beteiligungs GmbH City and country of registered office: Vienna, Austria
4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3
Mohammed Al Sheikh
Abdulmohsen Al Sheikh
5. Date on which threshold was crossed or reached
21.01.2021
6. Total positions
| % of voting rights attached to shares (total of 7.a.) |
% of voting rights through instruments (total of 7.b.1 + 7.b.2) |
total of both in % (7.a. + 7.b.) |
total number of voting rights of issuer |
|
|---|---|---|---|---|
| Resulting situation on the date on which threshold was crossed / reached |
13.86 | 0.00 | 13.86 | 1,474,731 |
| Position of previous notification |
16.59 | 0.00 | 16.59 |
7. Notified details of the resulting situation
7.a. Voting rights attached to shares
| ISIN code | absolute direct (Sec | absolute indirect | in % direct (Sec | in % indirect (Sec |
|---|---|---|---|---|
| 130 BörseG 2018) | (Sec 133 BörseG | 130 BörseG 2018) | 133 BörseG 2018) | |
| 2018) |
| ATMARINOMED6 | 0 | 204,410 | 0.00 | 13.86 |
|---|---|---|---|---|
| Total: | 204,410 | 13.86 |
7.b.1. Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG 2018
| Type of instrument | Expiration Date | Exercise Period | Voting Rights Absolute |
Voting Rights in % |
|---|---|---|---|---|
| Total: |
7.b.2 Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG 2018
| Type of | Expiration Date | Exercise Period | Physical /Cash | Voting Rights | Voting Rights in |
|---|---|---|---|---|---|
| instrument | Settlement | Absolute | % | ||
| Total: |
8. Information in relation to the person subject to the notification obligation
Full chain of controlled undertakings through which the voting rights and/or the financial/other instruments are effectively held starting with the ultimate controlling natural person or legal entity.
| No. | Name | Directly controlled by No. |
Shares held directly (%) |
Financial/other instruments held directly (%) |
Total of both (%) |
|---|---|---|---|---|---|
| 1 | Abdulmohsen Al Sheikh |
||||
| 2 | Mohammed Al Sheikh |
||||
| 3 | Acropora Beteiligungs GmbH |
1,2 | 13.86 | 13.86 |
9. In case of proxy voting
Date of general meeting: N/A
10. Additional Information
The participation notification is based on the fact that the threshold is not reached after the sale of 38,450 shares.
| emitter: | Marinomed Biotech AG Hovengasse 25 2100 Korneuburg Austria |
|---|---|
| contact person: | Elisabeth Schön |
| phone: | +43226290300 |
| e-mail: | [email protected] |
| website: | www.marinomed.com |
| ISIN(s): | ATMARINOMED6 (share) |
| stock exchanges: | official trade in Vienna |
News transmitted by pressetext.adhoc. The emitter is responsible for the content.